The role of systemic, spinal and supraspinal L-arginine-nitric oxide-cGMP pathway in thermal hyperalgesia caused by intrathecal injection of glutamate in mice

Neuropharmacology

Volumn 38, Issue 6, 1999, Pages 835-842

  Ferreira, Juliano ^a   Santos, Adair R S ^a   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Intrathecal injection; L Arginine nitric oxide cGMP pathway; Thermal hyperalgesia

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 6 ANILINO 5,8 QUINOLINEQUINONE; 8 BROMO CYCLIC GMP; ARGININE; CYCLIC GMP; DEXTRO ARGININE; GLUTAMIC ACID; METHYLENE BLUE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; N5 (1 IMINOETHYL)ORNITHINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HYPERALGESIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; ARGININE; CYCLIC GMP; ENZYME INHIBITORS; GLUTAMIC ACID; HEAT; HYPERALGESIA; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE;

EID: 0032949582     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00006-4     Document Type: Article

References (46)

1. Aanonsen L.M., Wilcox G.L. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. J. Pharmacol. Exp. Ther. 243:1987;9-19.
2. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 368:1994;850-852.
3. Bredt D.S., Hwang P.M., Snyder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 347:1990;768-770.
4. Brune B., Dimmeler S., Molina y Vedia L., Lapetina E.G. Nitric oxide: a signal for ADP-ribosylation of proteins. Life Sci. 54:1994;61-70.
5. Brune B., Lapetina E.G. Activation of cytosolic ADP-ribosyltransferase by nitric oxide-generating agents. J. Biol. Chem. 264:1989;8455-8458.
6. Brunner F., Stessel H., Kukovetz W.R. Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin-1 secretion. FEBS Lett. 376:1995;262-266.
7. Cahusac P.M.B., Evans R.H., Hill R.G., Rodriquez R.E., Smith D.A.S. The behavioral effects of an N-methylaspartate receptor antagonist following application to the lumbar spinal cord of conscious rats. Neuropharmacology. 23:1984;719-724.
8. Cellek S., Kasakov L., Moncada S. Inhibition of nitrergic relaxations by a selective inhibitor of the soluble guanylate cyclase. Br. J. Pharmacol. 118:1996;137-140.
9. Christopherson K.S., Bredt D.S. Nitric oxide in excitable tissues: physiological roles and disease. J. Clin. Invest. 100:1997;2424-2429.
10. Clancy R.M., Levartovsky D., Leszczynska-Piziak J., Yegudin J., Abramson S.B. Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: evidence for S-nitrosoglutathione as a bioactive intermediary. Proc. Natl. Acad. Sci. USA. 91:1994;3680-3684.
11. Dickenson A.H., Aydar E. Antagonism at the glycine site on the NMDA receptor reduces spinal nociception in the rat. Neurosci. Lett. 121:1991;263-266.
12. Dickenson A.H. Spinal cord pharmacology of pain. Br. J. Anaesth. 75:1995;193-200.
13. Eddy N.B., Leimback D. Synthetic analgesics II. Dithienylbutenyl and dithienylbutylamines. J. Pharmacol. Exp. Ther. 107:1953;385-393.
14. Fedele E., Jin Y., Varnier G., Raiteri M. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway. Br. J. Pharmacol. 119:1996;590-594.
15. Ferreira S.H., Lorenzetti B.B. Glutamate spinal retrograde sensitization of primary sensory neurons associated with nociception. Neuropharmacology. 33:1994;1479-1485.
16. Garthwaite J., Boulton C.J. Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57:1995;683-706.
17. Garthwaite J., Charles S.L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intracellular messenger in the brain. Nature. 336:1988;385-388.
18. Garthwaite J., Southam E., Boulton C.L., Nielsen E.B., Schmidt K., Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48:1995;184-188.
19. Gordh T., Karlsten R., Kristensen J. Intervention with spinal NMDA, adenosine, and NO systems for pain modulation. Ann. Med. 27:1995;229-234.
20. Hudspith M.J. Glutamate: a role in normal brain function, anaesthesia, analgesia and CNS injury. Br. J. Anaesth. 78:1997;731-747.
21. Hylden J.K.L., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67:1980;313-316.
22. Jackson D.L., Graff C.B., Richardson J.D., Hargreaves K.M. Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats. Eur. J. Pharmacol. 284:1995;321-325.
23. Kitto K.F., Haley J.E., Wilcox G.L. Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci. Lett. 148:1992;1-5.
24. Kolhekar R., Meller S.T., Gebhart G.F. Characterization of the role of spinal N-methyl-D-aspartate receptors in thermal nociception in the rat. Neuroscience. 57:1993;385-395.
25. Laursen S.E., Belknap J.K. Intracerebroventricular injections in mice: some methodological refirements. J. Pharmacol. Methods. 16:1986;355-357.
26. Luo D., Das S., Vicent S.R. Effects of methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphorase. Eur. J. Pharmacol. 290:1995;247-251.
27. Malmberg A.B., Yaksh T.L. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science. 257:1992;1276-1279.
28. Malmberg A.B., Yaksh T.L. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain. 54:1993;291-300.
29. Mao J., Price D.D., Hayes R.L., Lu J., Mayer D.J. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy. Brain Res. 598:1992;271-278.
30. Mayer B., Brunner F., Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem. Pharmacol. 45:1993;367-374.
31. Meller S.T., Dykstra C., Gebhart G.F. Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex. Eur. J. Pharmacol. 214:1992b;93-96.
32. Meller S.T., Dykstra C., Gebhart G.F. Acute thermal hyperalgesia in the rat is produced by activation of N-methyl-D-aspartate receptors and protein kinase C and production of nitric oxide. Neuroscience. 71:1996;327-335.
33. Meller S.T., Gebhart G.F. Spinal mediators of hyperalgesia. Drugs. 47(suppl. 5):1994;10-20.
34. Meller S.T., Pechman P.S., Gebhart G.F., Mavest T.J. Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience. 50:1992a;7-10.
35. Mulsch A.R., Busse S., Liebau S., Förstermann U. LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase. J. Pharmacol. Exp. Ther. 247:1988;283-288.
36. Raigorodsky G., Urca G. Intrathecal N-methyl-D-aspartate (NMDA) activates both nociceptive and antinociceptive systems. Brain Res. 422:1987;158-162.
37. Ren K., Williams G.M., Hylden J.L.K., Rude M.A., Dubner R. The intrathecal administration of excitatory amino acid receptors antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats. Eur. J. Pharmacol. 219:1992;235-243.
38. Salter M., Strijbos P.L., Neale S., Duffy C., Follenfant R.L., Garthwaite J. The nitric oxide-cyclic GMP pathway is required for nociceptive signalling at specific loci within the somatosensory pathway. Neuroscience. 73:1996;649-655.
39. Schrammel A., Behrends S., Schmidt K., Koesling D., Mayer B. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol. Pharmacol. 50:1996;1-5.
40. Stamler J.S., Simon D.I., Osborne J.A., Mullins M.E., Jaraki O., Michel T., Singel D.J., Loscalzo J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. USA. 89:1992;444-448.
41. Thomas R.J. Excitatory amino acids in health and disease. J. Am. Geriatric Soc. 43:1995;1279-1289.
42. Urca G., Raigorodsky G. Behavioral classification of excitatory amino acid receptors in mouse spinal cord. Eur. J. Pharmacol. 153:1988;211-220.
43. Vaz Z.R., Cechinel Filho V., Yunes R.A., Calixto J.B. Antinociceptive action of 2-(4-Bromobenzoyl)-3-Methyl-4,6-Dimethoxy Benzofuran, a novel Xanthoxyline derivative on chemical and thermal models of nociception in mice. J. Phamacol. Exp. Ther. 278:1996;304-312.
44. Woolf C.J., Thompson S.W.N. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain. 44:1991;293-300.
45. Yun H.Y., Dawson V.L., Dawson T.M. Nitric oxide in health and disease of central nervous system. Mol. Psychiatry. 2:1997;300-310.
46. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.